Man Accused of Attempting to Assassinate Trump Wants to Represent Himself in Florida Case
Routh is scheduled to stand trial in September, a year after prosecutors say a Secret Service agent thwarted his attempt to shoot Trump as he played golf. Routh has pleaded not guilty to charges of attempting to assassinate a major presidential candidate, assaulting a federal officer, and several firearm violations.
Cannon closed the courtroom to reporters and the public for about an hour Thursday to discuss matters potentially involving attorney-client privilege. The public portion of the hearing resumed with Cannon questioning Routh for about 30 minutes on whether he understands the gravity of defending himself in a case where he could face imprisonment if convicted. 'Do you understand that self-representation is almost always a bad idea?' the judge asked Routh. 'Yes, your honor,' replied Routh, who described the extent of his education as two years of college after earning his GED certificate. Cannon also asked Routh if he understood the court's rules of evidence and federal criminal procedure. He told her: 'I have a book.' Cannon did not rule during the hearing. She said she would issue a written order later.
The US Supreme Court has held that criminal defendants have a right to represent themselves in court proceedings as long as they can show a judge they are competent to waive their right to be defended by an attorney. The judge told Routh she doesn't intend to delay the Sept. 8 start date of his trial even if she lets him represent himself. Routh told her that he understood and would be ready.
Prosecutors have said Routh methodically plotted to kill Trump for weeks before aiming a rifle through the shrubbery as Trump played golf on Sept. 15 at his West Palm Beach country club. A Secret Service agent spotted Routh before Trump came into view. Routh allegedly aimed his rifle at the agent, who opened fire, causing Routh to drop his weapon and flee without firing a shot. Law enforcement obtained help from a witness who prosecutors said informed officers that he saw a person fleeing. The witness was then flown in a police helicopter to a nearby interstate where Routh was arrested and the witnesses confirmed it was the person he had seen, prosecutors have said. In addition to the federal charges, Routh also has pleaded not guilty to state charges of terrorism and attempted murder.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Arabiya
3 minutes ago
- Al Arabiya
FDA vaccine chief leaving agency after less than three months
The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of biotech companies, patient groups, and conservative allies of President Donald Trump. Dr. Vinay Prasad did not want to be a distraction and was stepping down from his role as the FDA's top vaccine regulator to spend more time with his family, a spokesperson for the Department of Health and Human Services said in a statement late Tuesday. Two people familiar with the situation told The Associated Press that Prasad was ousted following several recent controversies. The people spoke on condition of anonymity to discuss internal personnel matters. Prasad joined the FDA in May after years as an academic researcher at the University of California, San Francisco, where he frequently criticized the FDA's approach to drug approvals and COVID-19 vaccines. His contrarian approach appeared to match FDA Commissioner Marty Makary, who repeatedly praised Prasad's work and intellect. But in recent weeks, Prasad became a target of conservative activists, including Laura Loomer, who flagged Prasad's past statements criticizing Trump and praising liberal independent Senator Bernie Sanders. 'How did this Trump-hating Bernie Bro get into the Trump admin???' Loomer posted on X last week. Prasad also attracted scrutiny for his handling of a recent safety issue surrounding the only approved gene therapy for Duchennes muscular dystrophy. Under his direction, shipments of the therapy were briefly halted after a series of patient deaths, then resumed late Monday following vocal pushback from families of boys with the fatal muscle-wasting disorder. Prasad has long been skeptical of the therapy and other muscular dystrophy drugs sold by the drugmaker Sarepta Therapeutics. As an academic, Prasad gained prominence by attacking the FDA for being too lenient in its standards for approving cancer drugs and other new therapies. That approach is at odds with Trump's Republican supporters, who generally favor speedier approvals and unfettered access to experimental treatments. During Trump's first term, he signed the 'Right to Try' law, a largely symbolic piece of legislation that won popular support from conservatives seeking to give dying patients expanded access to unproven drugs. Prasad's decision to pause Sarepta's therapy was criticized last week by a columnist and the editorial board of The Wall Street Journal. Separately, Prasad's division issued rejection letters this month to three small biotech firms seeking approval for new gene therapies. Prasad's predecessor in the role, Dr. Peter Marks, oversaw a steep rise in approvals for new gene therapies, which aim to treat or prevent disease by replacing or modifying a portion of patients' genetic code. Prasad has been an outspoken critic of Marks' leadership at FDA, which included overseeing the approval of the first COVID vaccines and therapies.
Al Arabiya
33 minutes ago
- Al Arabiya
US to impose 25 pct tariff on India from August 1: Trump
President Donald Trump said on Wednesday the United States will impose a 25 percent tariff on goods imported from India starting on Aug. 1. He said India, which has the world's fifth largest economy, will also face an unspecified penalty on Aug. 1, but did not elaborate on the amount or what it was for. 'While India is our friend, we have, over the years, done relatively little business with them because their Tariffs are far too high, among the highest in the World, and they have the most strenuous and obnoxious non-monetary Trade Barriers of any Country,' Trump wrote in a Truth Social post. 'They have always bought a vast majority of their military equipment from Russia, and are Russia's largest buyer of ENERGY, along with China, at a time when everyone wants Russia to STOP THE KILLING IN UKRAINE — ALL THINGS NOT GOOD!' India's commerce ministry, which is leading the trade negotiations with the United States, did not immediately respond to a request for comment. Trump's decision dashes hopes of a limited trade agreement between the two countries, which had been under negotiation for several months. US and Indian trade negotiators had held multiple rounds of discussions to resolve contentious issues, particularly over market access for American agricultural and dairy products. Despite progress in some areas, Indian officials resisted opening the domestic market to imports of wheat, corn, rice and genetically modified soybeans, citing risks to the livelihood of millions of Indian farmers. The new tariffs are expected to impact India's goods exports to the US, estimated at around $87 billion in 2024, including labor-intensive products such as garments, pharmaceuticals, gems and jeweler, and petrochemicals. The United States currently has a $45.7 billion trade deficit with India. India now joins a growing list of countries facing higher tariffs under Trump's 'Liberation Day' trade policy, aimed at reshaping US trade relations by demanding greater reciprocity. The White House had previously warned India about its high average applied tariffs — nearly 39 percent on agricultural products, with rates climbing to 45 percent on vegetable oils and around 50 percent on apples and corn. The setback comes despite earlier commitments by Prime Minister Narendra Modi and Trump to conclude the first phase of a trade deal by autumn 2025 and expand bilateral trade to $500 billion by 2030, up from $191 billion in 2024.
Arab News
33 minutes ago
- Arab News
Trump envoy Witkoff heading to Israel for Gaza talks, Axios reports
WASHINGTON: US envoy Steve Witkoff is expected to travel to Israel on Wednesday for talks on the humanitarian crisis in Gaza, Axios reported, citing two US officials.
